Technical Analysis for PROG - Progenity, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | N/A | Up | Up |
Historical PROG trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Narrow Range Bar | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
NR7-2 | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
MACD Bullish Signal Line Cross | Bullish | -0.32% | |
NR7 | Range Contraction | -0.32% | |
Wide Bands | Range Expansion | -0.32% | |
Wide Bands | Range Expansion | 1.47% | |
Crossed Above 20 DMA | Bullish | -1.90% | |
Pocket Pivot | Bullish Swing Setup | -1.90% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
60 Minute Opening Range Breakdown | about 17 hours ago | |
Fell Below 10 DMA | about 17 hours ago | |
Fell Below Previous Day's Low | about 18 hours ago | |
60 Minute Opening Range Breakout | about 19 hours ago | |
10 DMA Support | about 20 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: ???
Progenity, Inc. Description
Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages. The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Disease Drug Delivery In Vitro Genomics Precision Medicine Systems Biology Proteomics Systems Science
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 15.92 |
52 Week Low | 3.08 |
Average Volume | 980,936 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 4.91 |
20-Day Moving Average | 5.84 |
10-Day Moving Average | 6.00 |
Average True Range | 0.64 |
ADX | 26.82 |
+DI | 27.75 |
-DI | 17.04 |
Chandelier Exit (Long, 3 ATRs ) | 5.63 |
Chandelier Exit (Short, 3 ATRs ) | 6.59 |
Upper Bollinger Band | 6.77 |
Lower Bollinger Band | 4.90 |
Percent B (%b) | 0.69 |
BandWidth | 32.09 |
MACD Line | 0.27 |
MACD Signal Line | 0.26 |
MACD Histogram | 0.0037 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 6.67 | ||||
Resistance 3 (R3) | 6.63 | 6.45 | 6.59 | ||
Resistance 2 (R2) | 6.45 | 6.33 | 6.46 | 6.56 | |
Resistance 1 (R1) | 6.32 | 6.26 | 6.39 | 6.36 | 6.54 |
Pivot Point | 6.14 | 6.14 | 6.17 | 6.15 | 6.14 |
Support 1 (S1) | 6.01 | 6.02 | 6.08 | 6.05 | 5.86 |
Support 2 (S2) | 5.83 | 5.95 | 5.84 | 5.84 | |
Support 3 (S3) | 5.70 | 5.83 | 5.81 | ||
Support 4 (S4) | 5.74 |